Tech Company Financing Transactions
Devax Funding Round
Devax, based in Lake Forest, secured $32 million in funding from InterWest Partners and U.S. Venture Partners.
Transaction Overview
Company Name
Announced On
11/2/2005
Transaction Type
Venture Equity
Amount
$32,000,000
Round
Series D
Investors
InterWest Partners (Lead Investor) (Michael Sweeney)
U.S. Venture Partners (Casey Tansey)
Proceeds Purpose
The funding will be used to finance the Company's US IDE clinical study and international marketing of the Axxess" drug eluting bifurcation stent.
Company Information
Company Status
Out of Business
Industry
Medical Devices & Instruments
Mailing Address
20996 Bake Parkway 106
Lake Forest, CA 92630
USA
Lake Forest, CA 92630
USA
Phone
Website
Email Address
Overview
Devax, Inc., a private emerging medical device company located in Irvine, California, is engaged in the development of a proprietary bifurcated stent system that provides a clinical solution to treat atherosclerotic disease in coronary bifurcations and left main coronary arteries.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeff Thiel
Browse more venture capital transactions:
Prev: 11/2/2005: Peppercoin venture capital transaction
Next: 11/2/2005: Iconoculture venture capital transaction
Share this article
Where The Data Comes From
We record every notable VC transaction. VC transactions on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs